{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:22:00Z","timestamp":1790644920998,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Korean Neuropsychiatry Association Haesong research grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although valproate and lithium are most commonly prescribed for bipolar disorder patients, studies comparing their effects on the risk of dementia are limited. Choosing a safer mood stabilizer is clinically crucial as elderly bipolar disorder patients are at high risk of dementia onset. Therefore, we aim to evaluate and compare the effects of valproate and lithium on the risk of dementia in elderly bipolar disorder patients. This study involved 4784 bipolar disorder patients aged 50\u00a0years or older from the Korean Health Insurance Review and Assessment Service database. We estimated the risk of dementia in valproate-only users, lithium-only users, and both users compared to both medication non-users using multivariable Cox proportional hazard models. Compared to non-users, valproate-only users and both users showed a higher risk of dementia (59% and 62%, respectively). In sub-group analysis, valproate increased the dementia risk when prescribed for at least 59\u00a0days or 23 cumulative defined daily doses. However, the dementia risk associated with lithium is unclear. Therefore, we concluded that lithium has the potential to be the safer choice as a mood stabilizer over valproate for elderly bipolar disorder patients considering the risk of dementia.<\/jats:p>","DOI":"10.1038\/s41598-022-18350-1","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T10:03:12Z","timestamp":1660903392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effect of valproate and lithium on dementia onset risk in bipolar disorder patients"],"prefix":"10.1038","volume":"12","author":[{"given":"Woori","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjeong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juyoung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Soo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Woong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"18350_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1176\/appi.ajgp.13.4.305","volume":"13","author":"M Sajatovic","year":"2005","unstructured":"Sajatovic, M. et al. Maintenance treatment outcomes in older patients with bipolar I disorder. Am. J. Geriatr. Psychiatry 13, 305\u2013311. https:\/\/doi.org\/10.1176\/appi.ajgp.13.4.305 (2005).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"18350_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jad.2016.12.003","volume":"210","author":"RJ Baldessarini","year":"2017","unstructured":"Baldessarini, R. J. et al. Differential associations of affective temperaments and diagnosis of major affective disorders with suicidal behavior. J. Affect Disord. 210, 19\u201321. https:\/\/doi.org\/10.1016\/j.jad.2016.12.003 (2017).","journal-title":"J. Affect Disord."},{"key":"18350_CR3","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.psychres.2016.10.030","volume":"246","author":"P Solano","year":"2016","unstructured":"Solano, P. et al. A Google-based approach for monitoring suicide risk. Psychiatry Res. 246, 581\u2013586. https:\/\/doi.org\/10.1016\/j.psychres.2016.10.030 (2016).","journal-title":"Psychiatry Res."},{"key":"18350_CR4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/ijnp\/pyx032","volume":"20","author":"B Sol\u00e9","year":"2017","unstructured":"Sol\u00e9, B. et al. Cognitive impairment in bipolar disorder: Treatment and prevention strategies. Int. J. Neuropsychopharmacol. 20, 670\u2013680. https:\/\/doi.org\/10.1093\/ijnp\/pyx032 (2017).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"18350_CR5","doi-asserted-by":"publisher","unstructured":"Bharadwaj, R. Cognitive impairment in euthymic patients with bipolar disorder. Br. J. Psychiatry 189, 468\u2013469; author reply 469, https:\/\/doi.org\/10.1192\/bjp.189.5.468b (2006).","DOI":"10.1192\/bjp.189.5.468b"},{"key":"18350_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1399-5618.2004.00111.x","volume":"6","author":"A Martinez-Aran","year":"2004","unstructured":"Martinez-Aran, A. et al. Cognitive impairment in euthymic bipolar patients: Implications for clinical and functional outcome. Bipolar Disord. 6, 224\u2013232. https:\/\/doi.org\/10.1111\/j.1399-5618.2004.00111.x (2004).","journal-title":"Bipolar Disord."},{"key":"18350_CR7","doi-asserted-by":"publisher","first-page":"434","DOI":"10.9758\/cpn.2018.16.4.434","volume":"16","author":"YS Woo","year":"2018","unstructured":"Woo, Y. S. et al. Korean medication algorithm project for bipolar disorder 2018 (KMAP-BP 2018): Fourth revision. Clin. Psychopharmacol. Neurosci. 16, 434\u2013448. https:\/\/doi.org\/10.9758\/cpn.2018.16.4.434 (2018).","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"18350_CR8","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroscience.2007.09.063","volume":"150","author":"C Nocjar","year":"2007","unstructured":"Nocjar, C., Hammonds, M. D. & Shim, S. S. Chronic lithium treatment magnifies learning in rats. Neuroscience 150, 774\u2013788. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.09.063 (2007).","journal-title":"Neuroscience"},{"key":"18350_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040182","volume":"4","author":"K Watase","year":"2007","unstructured":"Watase, K. et al. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model. PLoS Med. 4, e182. https:\/\/doi.org\/10.1371\/journal.pmed.0040182 (2007).","journal-title":"PLoS Med."},{"key":"18350_CR10","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/gbb.12071","volume":"12","author":"MK King","year":"2013","unstructured":"King, M. K. & Jope, R. S. Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome. Genes Brain Behav. 12, 723\u2013731. https:\/\/doi.org\/10.1111\/gbb.12071 (2013).","journal-title":"Genes Brain Behav."},{"key":"18350_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/009841096160925","volume":"49","author":"H Harada","year":"1996","unstructured":"Harada, H., Sugiyama, T. & Suketa, Y. Characterization of inhibition by chronic treatment with lithium ion on nerve growth factor-induced neuronal differentiation of rat PC12 pheochromocytoma cells. J. Toxicol. Environ. Health 49, 197\u2013206. https:\/\/doi.org\/10.1080\/009841096160925 (1996).","journal-title":"J. Toxicol. Environ. Health"},{"key":"18350_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0924-977x(96)00388-4","volume":"7","author":"RW Licht","year":"1997","unstructured":"Licht, R. W., Smith, D. & Braendgaard, H. The effect of chronic lithium treatment on the calibre of axons and nerve fibres in the rat sural nerve. Eur. Neuropsychopharmacol. 7, 95\u201398. https:\/\/doi.org\/10.1016\/s0924-977x(96)00388-4 (1997).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"18350_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brainresbull.2009.09.003","volume":"81","author":"XZ Zhang","year":"2010","unstructured":"Zhang, X. Z., Li, X. J. & Zhang, H. Y. Valproic acid as a promising agent to combat Alzheimer\u2019s disease. Brain Res. Bull. 81, 3\u20136. https:\/\/doi.org\/10.1016\/j.brainresbull.2009.09.003 (2010).","journal-title":"Brain Res. Bull."},{"key":"18350_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jchemneu.2016.09.003","volume":"78","author":"JU Welbat","year":"2016","unstructured":"Welbat, J. U. et al. Fluoxetine prevents the memory deficits and reduction in hippocampal cell proliferation caused by valproic acid. J. Chem. Neuroanat. 78, 112\u2013118. https:\/\/doi.org\/10.1016\/j.jchemneu.2016.09.003 (2016).","journal-title":"J. Chem. Neuroanat."},{"key":"18350_CR15","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.neuroscience.2012.08.060","volume":"225","author":"S Chaudhary","year":"2012","unstructured":"Chaudhary, S. & Parvez, S. An in vitro approach to assess the neurotoxicity of valproic acid-induced oxidative stress in cerebellum and cerebral cortex of young rats. Neuroscience 225, 258\u2013268. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.08.060 (2012).","journal-title":"Neuroscience"},{"key":"18350_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1399-5618.2009.00788.x","volume":"12","author":"LV Kessing","year":"2010","unstructured":"Kessing, L. V., Forman, J. L. & Andersen, P. K. Does lithium protect against dementia?. Bipolar Disord. 12, 87\u201394. https:\/\/doi.org\/10.1111\/j.1399-5618.2009.00788.x (2010).","journal-title":"Bipolar Disord."},{"key":"18350_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1192\/bjp.bp.114.154047","volume":"207","author":"T Gerhard","year":"2015","unstructured":"Gerhard, T., Devanand, D. P., Huang, C., Crystal, S. & Olfson, M. Lithium treatment and risk for dementia in adults with bipolar disorder: Population-based cohort study. Br. J. Psychiatry 207, 46\u201351. https:\/\/doi.org\/10.1192\/bjp.bp.114.154047 (2015).","journal-title":"Br. J. Psychiatry"},{"key":"18350_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jad.2016.05.010","volume":"201","author":"PS Tsai","year":"2016","unstructured":"Tsai, P. S., Liu, I. C., Chiu, C. H., Huang, C. J. & Wang, M. Y. Effect of valproic acid on dementia onset in patients with bipolar disorder. J. Affect. Disord. 201, 131\u2013136. https:\/\/doi.org\/10.1016\/j.jad.2016.05.010 (2016).","journal-title":"J. Affect. Disord."},{"key":"18350_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.brainres.2009.09.051","volume":"1302","author":"Y Qian","year":"2009","unstructured":"Qian, Y., Zheng, Y. & Tiffany-Castiglioni, E. Valproate reversibly reduces neurite outgrowth by human SY5Y neuroblastoma cells. Brain Res. 1302, 21\u201333. https:\/\/doi.org\/10.1016\/j.brainres.2009.09.051 (2009).","journal-title":"Brain Res."},{"key":"18350_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jad.2019.08.008","volume":"261","author":"A Pigoni","year":"2020","unstructured":"Pigoni, A. et al. A focus on valproate and cognitive deficits in bipolar disorders: A mini-review: Special section on \u201cTranslational and Neuroscience Studies in Affective Disorders\u201d Section Editor, Maria Nobile MD, PhD. J. Affect. Disord. 261, 277\u2013281. https:\/\/doi.org\/10.1016\/j.jad.2019.08.008 (2020).","journal-title":"J. Affect. Disord."},{"key":"18350_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1192\/bjp.bp.110.080044","volume":"198","author":"OV Forlenza","year":"2011","unstructured":"Forlenza, O. V. et al. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: Randomised controlled trial. Br. J. Psychiatry 198, 351\u2013356. https:\/\/doi.org\/10.1192\/bjp.bp.110.080044 (2011).","journal-title":"Br. J. Psychiatry"},{"key":"18350_CR22","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1192\/bjp.2019.76","volume":"215","author":"OV Forlenza","year":"2019","unstructured":"Forlenza, O. V., Radanovic, M., Talib, L. L. & Gattaz, W. F. Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: Randomised clinical trial. Br. J. Psychiatry 215, 668\u2013674. https:\/\/doi.org\/10.1192\/bjp.2019.76 (2019).","journal-title":"Br. J. Psychiatry"},{"key":"18350_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1567205011310010014","volume":"10","author":"MA Nunes","year":"2013","unstructured":"Nunes, M. A., Viel, T. A. & Buck, H. S. Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer\u2019s disease. Curr. Alzheimer Res. 10, 104\u2013107. https:\/\/doi.org\/10.2174\/1567205011310010014 (2013).","journal-title":"Curr. Alzheimer Res."},{"key":"18350_CR24","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.4088\/JCP.15m10304","volume":"78","author":"C Cheng","year":"2017","unstructured":"Cheng, C. et al. Association between lithium use and risk of Alzheimer\u2019s disease. J. Clin. Psychiatry 78, e139\u2013e145. https:\/\/doi.org\/10.4088\/JCP.15m10304 (2017).","journal-title":"J. Clin. Psychiatry"},{"key":"18350_CR25","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.4088\/JCP.08r04972","volume":"70","author":"AP Wingo","year":"2009","unstructured":"Wingo, A. P., Wingo, T. S., Harvey, P. D. & Baldessarini, R. J. Effects of lithium on cognitive performance: A meta-analysis. J. Clin. Psychiatry 70, 1588\u20131597. https:\/\/doi.org\/10.4088\/JCP.08r04972 (2009).","journal-title":"J. Clin. Psychiatry"},{"key":"18350_CR26","first-page":"S178","volume":"13","author":"RH Perlis","year":"2007","unstructured":"Perlis, R. H. Treatment of bipolar disorder: The evolving role of atypical antipsychotics. Am. J. Manag. Care 13, S178-188 (2007).","journal-title":"Am. J. Manag. Care"},{"key":"18350_CR27","doi-asserted-by":"publisher","unstructured":"Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association. Am. J. Psychiatry 151, 1\u201336, https:\/\/doi.org\/10.1176\/ajp.151.12.1 (1994).","DOI":"10.1176\/ajp.151.12.1"},{"key":"18350_CR28","unstructured":"Sachs, G. S., Printz, D. J., Kahn, D. A., Carpenter, D. & Docherty, J. P. The expert consensus guideline series: Medication treatment of bipolar disorder 2000. Postgrad. Med. Spec No 1-104 (2000)."},{"key":"18350_CR29","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","volume":"47","author":"M Charlson","year":"1994","unstructured":"Charlson, M., Szatrowski, T. P., Peterson, J. & Gold, J. Validation of a combined comorbidity index. J. Clin. Epidemiol. 47, 1245\u20131251. https:\/\/doi.org\/10.1016\/0895-4356(94)90129-5 (1994).","journal-title":"J. Clin. Epidemiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18350-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18350-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18350-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T07:16:36Z","timestamp":1669360596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18350-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18350"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18350-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"assertion":[{"value":"11 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14142"}}